Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00889564 · ClinicalTrials.gov registry record · NA
HeRO Vascular Access Device Bacteremia Study
A NA study, sponsored by Merit Medical Systems.
- Completed
- Registry status
- NA
- Development phase
- 38
- Enrollment target
NCT00889564 is a NA study that has completed, run by Merit Medical Systems. The registered enrollment target is 38 participants.
The verdict
NCT00889564, a NA study, has completed, sponsored by Merit Medical Systems.
- COMPLETED
- Registry status
- NA
- Development phase
- 38 participants
- Enrollment target
Study Summary
The purpose of this study is to compare the safety and effectiveness of the HeRO Vascular Access Device in access challenged (e.g., catheter-dependent) hemodialysis patients. It is hypothesized the bacteremia rate associated with the HeRO device will be lower than a historical literature control of tunneled dialysis catheters.
Interventions
- DEVICE HeRO Vascular Access Device
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 38 participants |
| Start Date | 2006-03 |
| Est. Completion | 2007-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00889564
The ClinicalTrials.gov registry entry for NCT00889564 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 38 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Merit Medical Systems, which has 18 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which HeRO Vascular Access Device is the first listed.
NCT00889564 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00889564 about?
NCT00889564 is a clinical study titled "HeRO Vascular Access Device Bacteremia Study". The purpose of this study is to compare the safety and effectiveness of the HeRO Vascular Access Device in access challenged (e.g., catheter-dependent) hemodialysis patients. It is hypothesized the bacteremia rate associated with the HeRO device will be lower than a historical literature control of ...
What is the current status of trial NCT00889564?
This trial is currently completed. It is a NA study. The enrollment target is 38 participants. The study started on 2006-03. Estimated completion is 2007-03.
What interventions are being tested in trial NCT00889564?
The interventions under investigation include: HeRO Vascular Access Device (DEVICE).
Who is sponsoring clinical trial NCT00889564?
This trial is sponsored by Merit Medical Systems, which has 18 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.